BioNTech's R&D programs developed and produced 4 Bn COVID-19 vaccine doses as of 2022
Register to read the full analysis —or— Upgrade to access more features
#R&D
#covid-19
#disease
#infectious disease
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.